Prolonged NMDA-mediated responses, altered ifenprodil sensitivity, and epileptiform-like events in the malformed hippocampus of methylazoxymethanol exposed rats

Journal of Neurophysiology

Volumn 94, Issue 1, 2005, Pages 153-162

  Calcagnotto, Maria Elisa ^a   Baraban, Scott C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Box 0520 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; GLUTAMIC ACID; IFENPRODIL; METHYLAZOXYMETHANOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MALFORMATION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIVITY; ELECTRIC POTENTIAL; ELECTROSTIMULATION; EPILEPTIC DISCHARGE; EPILEPTOGENESIS; EVOKED EXCITATORY POSTSYNAPTIC CURRENT; EVOKED RESPONSE; FEMALE; HETEROTOPIA; HIPPOCAMPUS; NEUROPATHOLOGY; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SYNAPTIC TRANSMISSION; VOLTAGE CLAMP;

ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EPILEPSY; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; METHYLAZOXYMETHANOL ACETATE; N-METHYLASPARTATE; PATCH-CLAMP TECHNIQUES; PIPERIDINES; RATS;

EID: 21544470524     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.01155.2004     Document Type: Article

References (103)

1. Andre VM, Flores-Hernandez J, Cepeda C, Starling AJ, Nguyen S, Lobo MK, Vinters HV, Levine MS, and Mathern GW. NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue. Cereb Cortex 14: 634-646, 2004.
2. Atluri PP and Regehr WG. Delayed release of neurotransmission from cerebellar granule cells. J Neurosci 18: 8214-8227, 1998.
3. Babb TL, Ying Z, Hadam J, and Penrod C. Glutamate receptor mechanisms in human epileptic dysplastic cortex. Epilepsy Res 32: 24-33, 1998.
4. Balduini W, Cimino M, Lombardelli G, Abbracchio MP, Peruzzi G, Cecchini T, Gazzanelli GC, and Cattabeni F. Microencephalic rats as a model for cognitive disorders. Clin Neuropharmacol 9 Suppl 3: S8-18, 1986.
5. Baraban SC and Schwartzkroin PA. Flurothyl seizure susceptibility in rats following prenatal methylazoxymethanol treatment. Epilepsy Res 23: 189-194, 1996.
6. Baraban SC, Wenzel HJ, Hochman DW, and Schwartzkroin PA. Characterization of heterotopic cell clusters in the hippocampus of rats exposed to methylazoxymethanol in utero. Epilepsy Res 39: 87-102, 2000.
7. Barbour B, Keller BU, Llano I, and Marty A. Prolonged presence of glutamate during excitatory synaptic transmission to cerebellar Purkinje cells. Neuron 12: 1331-1343, 1994.
8. Barth AL and Malenka RC. NMDAR EPSC kinetics do not regulate the critical period for LTP at thalamocortical synapses. Nat Neurosci 4: 235-236, 2001.
9. Battaglia G, Pagliardini S, Ferrario A, Gardoni F, Tassi L, Setola V, Garbelli R, LoRusso G, Spreafico R, Di Luca M, and Avanzini G. AlphaCaMKII and NMDA-receptor subunit expression in epileptogenic cortex from human periventricular nodular heterotopia. Epilepsia 43 Suppl 5: S209-216, 2002.
10. Beaton JA, Stemsrud K, and Monaghan DT. Identification of a novel N-methyl-D-aspartate receptor population in the rat medial thalamus. J Neurochem 59: 754-757, 1992.
11. Brimecombe JC, Boeckman FA, and Aizenman E. Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 94: 11019-11024, 1997.
12. Buller AL, Larson HC, Schneider BE, Beaton JA, Morrisett RA, and Monaghan DT. The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition. J Neurosci 14: 5471-5484, 1994.
13. Buller AL and Monaghan DT. Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes. Eur J Pharmacol 320: 87-94, 1997.
14. Calcagnotto ME, Paredes MF, and Baraban SC. Heterotopic neurons with altered inhibitory synaptic function in an animal model of malformation- associated epilepsy. J Neurosci 22: 7596-7605, 2002.
15. Caputi A, Gardoni F, Cimino M, Pastorino L, Cattabeni F, and Di Luca M. CaMKII-dependent phosphorylation of NR2A and NR2B is decreased in animals characterized by hippocampal damage and impaired LTP. Eur J Neurosci 11: 141-148, 1999.
16. Carroll RC and Zukin RS. NMDA-receptor trafficking and targeting: implications for synaptic transmission and plasticity. Trends Neurosci 25: 571-577, 2002.
17. Castro PA, Cooper EC, Lowenstein DH, and Baraban SC. Hippocampal heterotopia lack functional Kv4.2 potassium channels in the methylazoxymethanol model of cortical malformations and epilepsy. J Neurosci 21: 6626-6634, 2001.
18. Castro PA, Pleasure SJ, and Baraban SC. Hippocampal heterotopia with molecular and electrophysiological properties of neocortical neurons. Neuroscience 114: 961-972, 2002.
19. Chen C and Regehr WG. Contributions of residual calcium to fast synaptic transmission. J Neurosci 19: 6257-6266, 1999.
20. Chen N, Luo T, and Raymond LA. Subtype-dependence of NMDA receptor channel open probability. J Neurosci 19: 6844-6854, 1999.
21. Chen N, Ren J, Raymond LA, and Murphy TH. Changes in agonist concentration dependence that are a function of duration of exposure suggest N-methyl-D -aspartate receptor nonsaturation during synaptic stimulation. Mol Pharmacol 59: 212-219, 2001.
22. Chen S and Diamond JS. Synaptically released glutamate activates extrasynaptic NMDA receptors on cells in the ganglion cell layer of rat retina. J Neurosci 22: 2165-2173, 2002.
23. Chevassus-au-Louis N, Ben-Ari Y, and Vergnes M. Decreased seizure threshold and more rapid rate of kindling in rats with cortical malformation induced by prenatal treatment with methylazoxymethanol. Brain Res 812: 252-255, 1998a.
24. Chevassus-au-Louis N, Rafiki A, Jorquera I, Ben-Ari Y, and Represa A. Neocortex in the hippocampus: an anatomical and functional study of CAI heterotopias after prenatal treatment with methylazoxymethanol in rats. J Comp Neurol 394: 520-536, 1998b.
25. Colacitti C, Sancini G, DeBiasi S, Franceschetti S, Caputi A, Frassoni C, Cattabeni F, Avanzini G, Spreafico R, Di Luca M, and Battaglia G. Prenatal methylazoxymethanol treatment in rats produces brain abnormalities with morphological similarities to human developmental brain dysgeneses. J Neuropathol Exp Neurol 58: 92-106, 1999.
26. Crino PB, Duhaime AC, Baltuch G, and White R. Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia. Neurology 56: 906-913, 2001.
27. Cull-Candy S, Brickley S, and Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11: 327-335, 2001.
28. Dalby NO and Mody I. Decreased sensitivity to ifenprodil of an augmented NMDA receptor-mediated input to kindled dentate gyrus granule cells (Abstract). Epilepsia 44 Suppl 9: S20, 2003.
29. Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE, Dikkes P, Conner DA, Rayudu PV, Cheung W, Chen HS, Lipton SA, and Nakanishi N. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393: 377-381, 1998.
30. Davies J and Watkins JC. Role of excitatory amino acid receptors in mono- and polysynaptic excitation in the cat spinal cord. Exp Brain Res 49: 280-290, 1983.
31. DeFazio RA and Hablitz JJ. Alterations in NMDA receptors in a rat model of cortical dysplasia. J Neurophysiol 83: 315-321, 2000.
32. de Feo MR, Mecarelli O, and Ricci GF. Seizure susceptibility in immature rats with micrencephaly induced by prenatal exposure to methylazoxymethanol acetate. Pharmacol Res 31: 109-114, 1995.
33. Diamond JS. Neuronal glutamate transporters limit activation of NMDA receptors by neurotransmitter spillover on CA1 pyramidal cells. J Neurosci 21: 8328-8338, 2001.
34. Edmonds B, Gibb AJ, and Colquhoun D. Mechanisms of activation of glutamate receptors and the time course of excitatory synaptic currents. Annu Rev Physiol 57: 495-519, 1995.
35. Ehrlich I and Malinow R. Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity. J Neurosci 24: 916-927, 2004.
36. Eriksson M, Nilsson A, Froelich-Fabre S, Akesson E, Dunker J, Seiger A, Folkesson R, Benedikz E, and Sundstrom E. Cloning and expression of the human N-methyl-D-aspartate receptor subunit NR3A. Neurosci Lett 321: 177-181, 2002;
37. erratum in Neurosci Lett 331: 69-70, 2002.
38. Fleidervish IA, Binshtok AM, and Gutnick MJ. Functionally distinct NMDA receptors mediate horizontal connectivity within layer 4 of mouse barrel cortex. Neuron 21: 1055-1065, 1998.
39. Flint AC, Maisch US, Weishaupt JH, Kriegstein AR, and Monyer H. NR2A subunit expression shortens NMDA receptor synaptic currents in developing neocortex. J Neurosci 17: 2469-2476, 1997.
40. Fox K, Sato H, and Daw N. The location and function of NMDA receptors in cat and kitten visual cortex. J Neurosci 9: 2443-2454, 1989.
41. Fox K, Sato H, and Daw N. The effect of varying stimulus intensity on NMDA-receptor activity in cat visual cortex. J Neurophysiol 64: 1413-1428, 1990.
42. Furshpan EJ and Potter DD. Seizure-like activity and cellular damage in rat hippocampal neurons in cell culture. Neuron 3: 199-207, 1989.
43. Gardoni F, Pagliardini S, Setola V, Bassanini S, Cattabeni F, Battaglia G, and Di Luca M. The NMDA receptor complex is altered in an animal model of human cerebral heterotopia. J Neuropathol Exp Neurol 62: 662-675, 2003.
44. Germano IM, Zhang YF, Sperber EF, and Moshe SL. Neuronal migration disorders increase susceptibility to hyperthermia-induced seizures in developing rats. Epilepsia 37: 902-910, 1996.
45. Glitsch M and Marty A. Presynaptic effects of NMDA in cerebellar Purkinje cells and interneurons. J Neurosci 19: 511-519, 1999.
46. Gourevitch R, Rocher C, Le Pen G, Krebs MO, and Jay TM. Working memory deficits in adult rats after prenatal disruption of neurogenesis. Behav Pharmacol 15: 287-292, 2004.
47. Hawkins LM, Chazot PL, and Stephenson FA. Biochemical evidence for the co-association of three N-methyl-D-aspartate (NMDA) R2 subunits in recombinant NMDA receptors. J Biol Chem 274: 27211-27218, 1999.
48. Hestrin S, Nicoll RA, Perkel DJ, and Sah P. Analysis of excitatory synaptic action in pyramidal cells using whole-cell recording from rat hippocampal slices. J Physiol 422: 203-225, 1990.
49. Huettner JE and Bean BP. Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci USA 85: 1307-1311, 1988.
50. Ikeda K, Nagasawa M, Mori H, Araki K, Sakimura K, Watanabe M, Inoue Y, and Mishina M. Cloning and expression of the epsilon 4 subunit of the NMDA receptor channel. FEBS Lett 313: 34-38, 1992.
51. Isaacson JS. Glutamate spillover mediates excitatory transmission in the rat olfactory bulb. Neuron 23: 377-384, 1999.
52. Iserhot C, Gloveli T, and Heinemann U. Effects of glutamate uptake blockers on stimulus-induced field potentials in rat entorhinal cortex in vitro. Neurosci Lett 259: 103-106, 1999.
53. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, and Masu M. Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268: 2836-2843, 1993.
54. Isokawa M and Mello LE. NMDA receptor-mediated excitability in dendritically deformed dentate granule cells in pilocarpine-treated rats. Neurosci Lett 129: 69-73, 1991.
55. Jacobs KM, Gutnick MJ, and Prince DA. Hyperexcitability in a model of cortical maldevelopment. Cereb Cortex 6: 514-523, 1996.
56. Jacobs KM, Hwang BJ, and Prince DA. Focal epileptogenesis in a rat model of polymicrogyria. J Neurophysiol 81: 159-173, 1999.
57. Johnston GA, Lodge D, Bornstein JC, and Curtis DR. Potentiation of L-glutamate and L-aspartate excitation of cat spinal neurones by the stereo-isomers of threo-3-hydroxyaspartate. J Neurochem 34: 241-243, 1980.
58. Kew JN, Richards JG, Mutel V, and Kemp JA. Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons. J Neurosci 18: 1935-1943, 1998.
59. 2+ fluctuations. J Neurobiol 37: 110-130, 1998.
60. Kullmann DM. Synaptic and extrasynaptic roles of glutamate in the mammalian hippocampus. Acta Physiol Scand 166: 79-83, 1999.
61. Kutsuwada T, Kashiwabuchi N, Mon H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, and Arakawa M. Molecular diversity of the NMDA receptor channel. Nature 358: 36-41, 1992.
62. Lester RA, Clements JD, Westbrook GL, and Jahr CE. Channel kinetics determine the time course of NMDA receptor-mediated synaptic currents. Nature 346: 565-567, 1990.
63. Liu H, Wang H, Sheng M, Jan LY, Jan YN, and Basbaum AI. Evidence for presynaptic N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc Natl Acad Sci USA 91: 8383-8387, 1994.
64. Lozovaya NA, Grebenyuk SE, Tsintsadze TSh, Feng B, Monaghan DT, and Krishtal OA. Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape "superslow" afterburst EPSC in rat hippocampus. J Physiol 558: 451-463, 2004a.
65. Lozovaya N, Melnik S, Tsintsadze T, Grebenyuk S, Kirichok Y, and Krishtal O. Protective cap over CA1 synapses: extrasynaptic glutamate does not reach the postsynaptic density. Brain Res 1011: 195-205, 2004b.
66. Luhmann HJ, Karpuk N, Qu M, and Zilles K. Characterization of neuronal migration disorders in neocortical structures. II. Intracellular in vitro recordings. J Neurophysiol 80: 92-102, 1998.
67. Mathern GW, Pretorius JK, Leite JP, Kornblum HI, Mendoza D, Lozada A, and Bertram EH 3rd. Hippocampal AMPA and NMDA mRNA levels and subunit immunoreactivity in human temporal lobe epilepsy patients and a rodent model of chronic mesial limbic epilepsy. Epilepsy Res 32: 154-171, 1998.
68. MacDonald JF, Miljkovic Z, and Pennefather P. Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J Neurophysiol 58: 251-266, 1987.
69. Meldrum BS. Excitatory amino acids in epilepsy and potential novel therapies. Epilepsy Res 12: 189-196, 1992.
70. Mody I and Heinemann U. NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling. Nature 326: 701-704, 1987.
71. 2+ release. Trends Pharmacol Sci 16: 356-359, 1995.
72. Monaghan DT, Andaloro VJ, and Skifter DA. Molecular determinants of NMDA receptor pharmacological diversity. Prog Brain Res 116: 171-190, 1998.
73. Monyer H, Burnashev N, Laurie DJ, Sakmann B, and Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12: 529-540, 1994.
74. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, and Seeburg PH. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256: 1217-1221, 1992.
75. Morishita W and Alger BE. Evidence for endogenous excitatory amino acids as mediators in DSI of GABA(A)ergic transmission in hippocampal CA1. J Neurophysiol 82: 2556-2564, 1999.
76. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, and Nakanishi S. Molecular cloning and characterization of the rat NMDA receptor. Nature 354: 31-37, 1991.
77. Najm IM, Ying Z, Babb T, Mohamed A, Hadam J, LaPresto E, Wyllie E, Kotagal P, Bingaman W, Foldvary N, Morris H, and Luders HO. Epileptogenicity correlated with increased N-methyl-D-aspartate receptor subunit NR2A/B in human focal cortical dysplasia. Epilepsia 41: 971-976, 2000.
78. Nishi M, Hinds H, Lu HP, Kawata M, and Hayashi Y. Motoneuron-specific expression of NR3B, a novel NMDA-type glutamate receptor subunit that works in a dominant-negative manner. J Neurosci 21: RC185, 2001.
79. Palmini A, Gambardella A, Andermann F, Dubeau F, da Costa JC, Olivier A, Tampieri D, Robitaille Y, Paglioli E, and Paglioli Neto E. Operative strategies for patients with cortical dysplastic lesions and intractable epilepsy. Epilepsia 35 Suppl 6: S57-71, 1994.
80. Paquet M and Smith Y. Presynaptic NMDA receptor subunit immunoreactivity in GABAergic terminals in rat brain. J Comp Neurol 423: 330-347, 2000.
81. Pentney AR, Baraban SC, and Colmers WF. NPY sensitivity and postsynaptic properties of heterotopic neurons in the MAM model of malformation-associated epilepsy. J Neurophysiol 88: 2745-2754, 2002.
82. Rafiki A, Chevassus-au-Louis N, Ben-Ari Y, Khrestchatisky M, and Represa A. Glutamate receptors in dysplasic cortex: an in situ hybridization and immunohistochemistry study in rats with prenatal treatment with methylazoxymethanol. Brain Res 782: 142-152, 1998.
83. Ramakers GM, Urban U, De Graan PN, Di Luca M, Cattabeni F, and Gispen WH. The impaired long-term potentiation in the CA1 field of the hippocampus of cognitive deficient microencephalic rats is restored by D-serine. Neuroscience 54: 49-60, 1993.
84. Roberts EB and Ramoa AS. Enhanced NR2A subunit expression and decreased NMDA receptor decay time at the onset of ocular dominance plasticity in the ferret. J Neurophysiol 81: 2587-2591, 1999.
85. Sancini G, Franceschetti S, Battaglia G, Colacitti C, Di Luca M, Spreafico R, and Avanzini G. Dysplastic neocortex and subcortical heterotopias in methylazoxymethanol-treated rats: an intracellular study of identified pyramidal neurones. Neurosci Lett 246: 181-185, 1998.
86. Shao LR and Dudek FE. Increased excitatory synaptic activity and local connectivity of hippocampal CA1 pyramidal cells in rats with kainate-induced epilepsy. J Neurophysiol 92: 1366-1373, 2004.
87. Sheng M, Cummings J, Roldan LA, Jan YN, and Jan LY. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368: 144-147, 1994.
88. Shi J, Aamodt SM, and Constantine-Paton M. Temporal correlations between functional and molecular changes in NMDA receptors and GABA neurotransmission in the superior colliculus. J Neurosci 15: 6264-6276, 1997.
89. Singh SC. Ectopic neurones in the hippocampus of the postnatal rat exposed to methylazoxymethanol during foetal development. Acta Neuropathol (Berl) 40: 111-116, 1977.
90. Singh SC. Redirected perforant and commissural of connections of eutopic and ectopic neurons in the hippocampus of methylazoxymethanol-acetate treated rats. Acta Neuropathol 44: 197-202, 1978.
91. Singh SC. Deformed dendrites and reduced spine numbers on ectopic neurones in the hippocampus of rats exposed to methylazoxymethanol-acetate. A Golgi-Cox study. Acta Neuropathol 49: 193-198, 1980.
92. Spreafico R, Pasquier B, Minotti L, Garbelli R, Kahane P, Grand S, Benabid AL, Tassi L, Avanzini G, Battaglia G, and Munari C. Immunocytochemical investigation on dysplastic human tissue from epileptic patients. Epilepsy Res 32: 34-48, 1998.
93. Stocca G and Vicini S. Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons. J Physiol 507: 13-24, 1998.
94. Stuart GJ, Dodt HU, and Sakmann B. Patch-clamp recordings from the soma and dendrites of neurons in brain slices using infrared video microscopy. Pfluegers 423: 511-518, 1993.
95. Swann JW and Hablitz JJ. Cellular abnormalities and synaptic plasticity in seizure disorders of the immature nervous system. Ment Retard Dev Disabil Res Rev 6: 258-267, 2000.
96. Tovar KR and Westbrook GL. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci 19: 4180-4188, 1999.
97. Vicini S, Wang JF, Li JH, Zhu WJ, Wang YH, Luo JH, Wolfe BB, and Grayson DR. Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors. J Neurophysiol 79: 555-566, 1998.
98. Wheal HV, Simpson L, Phelps S, and Stockley E. Excitatory amino acid receptor subtypes and their roles in epileptiform synaptic potentials in the hippocampus. In: Excitatory Amino Acids and Synaptic Function, edited by Wheal H and Thompson A. New York: Academic, 1991, p. 239-264.
99. Williams K. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44: 851-859, 1993.
100. Williams K, Russell SL, Shen YM, and Mollnoff PB. Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro. Neuron 10: 267-278, 1993.
101. Woodhall G, Evans DI, Cunningham MO, and Jones RS. NR2B-containing NMDA autoreceptors at synapses on entorhinal cortical neurons. J Neurophysiol 86: 1644-1651, 2001.
102. Ying Z, Babb TL, Comair YG, Bingaman W, Bushey M, and Touhalisky K. Induced expression of NMDAR2 proteins and differential expression of NMDAR1 splice variants in dysplastic neurons of human epileptic neocortex. J Neuropathol Exp Neurol 57: 47-62, 1998.
103. Ying Z, Babb TL, Mikuni N, Najm I, Drazba J, and Bingaman W. Selective coexpression of NMDAR2A/B and NMDAR1 subunit proteins in dysplastic neurons of human epileptic cortex. Exp Neurol 159: 409-418, 1999.